VIEW
IN BROWSER
EDITOR'S
NOTE: Big4Bio newsletters will not be
published on June 19th; they will resume
distribution on Monday, June 22nd.
|
|
| JUNE
18, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
| BIG4BIO
WEEKLY CEO Q&A: |
| No
new Q&A this week as we observe the
Juneteenth holiday — but we'll be back on
Monday with another life sciences CEO from
our coverage regions. In the meantime,
catch up on our features with Sean
McCarthy (CytomX), Maher Masoud (MaxCyte),
Robin Toft (Curebound), and Rick Batycky
(Nocion). More |
|
|
|
|
One Partner For Your Entire
Vivarium. Research Ready From Day
One. |
|
Learn More
→ |
|
|
- Corcept: Resubmits New Drug Application for
Relacorilant as a Treatment for Patients With
Cushing’s Syndrome More
- Genentech: FDA Accepts Supplemental
Biologics License Application for Lunsumio and
Polivy Combination for People With Relapsed or
Refractory Large B-Cell Lymphoma More
- IASO Bio: NDA Approval of Equecabtagene
Autoleucel by the Singapore Health Sciences
Authority (HSA) for the Treatment of Relapsed
or Refractory Multiple Myeloma, Marking a Key
Milestone in International Commercialization More
- 10x Genomics and Cleveland Clinic:
Collaborate to Advance Research in Diagnostic
Applications of Single Cell and Spatial
Technologies in Patients With Bladder Cancer More
- 23andMe Research Institute: Appoints Hillary
Aiken as Head of Philanthropy &
Development More
- VahatiCor: Enrolls First U.S. Patient in
SERRA-I Clinical Study of A-FLUX Reducer
System for CMD More
|
|
|
|
Investment Banking Advisory to the
Life Science Industry |
|
Learn More
→ |
|
|
- A Potential Billion-Dollar Deal Looks for
New Ways To Beat Back Cancer More*
More
More
More
- Biogen: Expands Immunology Pipeline With
Agreement to Acquire RayThera Inc. More
More*
- Cytokinetics: Inducement Grants Under Nasdaq
Listing Rule 5635(c)(4)
More
- Denali Therapeutics: Enters Agreement to
Sell Rare Pediatric Disease Priority Review
Voucher for $195 Million More
- Former Genentech Exec Moves Company to Bay
Area From Colorado With $400 Million in the
Bank More*
- Hackers Demand Payment for Stolen Data Tied
to Heart Monitoring Company iRhythm More*
- Invoke Bio, Immunectra Win $100K QB3
Mentoring Awards for Precision Cancer
Vaccines, MS Diagnostic More
- Kardigan: Pricing of Upsized Initial
Public Offering More
More*
More*
- Scribe Therapeutics: Awarded More Than $25
Million From CIRM to Accelerate Additional
CRISPR-Based Gene Editing Therapies for
Cardiometabolic Disease Into Clinical Trials More
- Sonire Therapeutics: Awarded $13 Million
Through NEDO Deep-Tech Startups Support
Program (DTSU) to Advance Global
Commercialization of Pancreatic Cancer
Treatment More
- Spot Biosystems: Launches With $40 Million
Financing and World-First Non-Viral Delivery
of Full-Length Dystrophin in Animal Models and
Human Patients With DMD More
More* More*
|
|
|
| Biotech’s
most flexible vivarium lab space
to launch and scale studies. |
|
Learn More
→ |
|
|
|
- Subscribe to LifeSci Startup for
Updates on US Startups More
- ZoBio Launches Comprehensive DEL Hit
Discovery Service for Challenging Targets More
|
|
- Telling Your Science Story to
Investors More
- AI in Biotech: The New
Frontier for Leadership & Strategy More
- Empowering Students Through STEM: A
Conversation With Massachusetts Science &
Engineering Fair Executive Director Helen
Rosenfeld More
- M&A in Life Sciences: The Turning Tide –
Why Now is a Strategic Inflection for
Biopharma and Biotech More
- More Than Executive Search: Building
Leadership for Every Stage of Growth More
- Novo’s M&A Leader Leaves for Forbion;
Perrigo CEO’s ‘Personal Conduct’ Issues Led to
Resignation More*
- Pharma Manufacturing Projected to Create
19,000 Jobs Through 2034 More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: SFBay Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
|
|
|
|
|
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:SFBay,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|